Cisternography with metrizamide of the posterior fossa following lateral C1-C2 puncture.
A report is given of a series of 23 consecutive cisternographies with metrizamide (Amipaque) of the posterior fossa using the lateral puncture at the C1-C2 level. Two to 4 ml metrizamide 300 mg I/ml were injected. The good clinical tolerance with regard to short as well as long-term effects of the contrast medium may be attributed to the low dose used and rendered possible by the selective distribution. No clinical epileptogenic seizures were observed.
D003388:Cranial Fossa, Posterior / Q000000981:diagnostic imaging*; D006801:Humans; D008793:Metrizamide / Q000008:administration & dosage; D009192:Myelography / Q000379:methods*; D011677:Punctures / Q000379:methods; D012886:Skull / Q000000981:diagnostic imaging*
D008793:Metrizamide